In 2020, according to IQVIA, the total spent on prescription drugs in the U.S. was $359 billion dollars with specialty prescriptions accounting for 53% of that total. This year, Segal predicts prescription costs to increase up to 8.4% in 2022 along with the costs of the specialty treatments for the diseases related to those prescriptions. What can employers do to combat the rising costs of employee care as it relates to prescription and disease management?
Healthgram’s advanced clinical infrastructure includes an in-house medical team with the expertise required to appropriately manage high-cost treatments that your employees need. That includes reviewing all specialty prescription and disease-related treatments through both a clinical and financial lens. Our approach ensures that both the provider and the patient are on the most appropriate course of care at the right place and for the right price. Most importantly, every process is built around helping the patient and supporting their needs.
High-cost specialty prescriptions and treatments can have a significant negative impact on your company’s bottom line if not properly managed. It’s imperative for employers to align with a proven health plan partner that is equipped to support employees and assist with complex clinical needs. Let’s design a cost-saving health benefits strategy together that keeps your employees and your bottom line healthy. Contact a member of our team today to get started.